Chemspeed Technologies (a Bruker company), a global leader in laboratory automation solutions, announces a strategic partnership with Iktos, a pioneer in artificial intelligence and robotics for drug discovery. Together, the companies deliver an integrated solution that combines AI‑driven synthesis planning and orchestration with Chemspeed’s highly configurable robotic platforms, enabling a new generation of automated workflows for pharmaceutical R&D. 

This collaboration brings AI‑orchestrated laboratory automation to pharmaceutical research teams, helping accelerate discovery programs, increase laboratory productivity, and expand the scope of automated chemical synthesis. 

At SLAS2026, Chemspeed Technologies, a leader in the automation and digitalization of R&D and QC laboratories, and SciY, a leader in scientific and laboratory management software focused on lab standardization and AI-readiness, today introduce their open Self‑Driving Lab (SDL) platform. Their Self-Driving Lab platform is designed to accelerate research and development (R&D), quality control (QC) and chemical and biomolecular manufacturing workflows. The SDL enables lab managers to operationalize autonomous, AI‑orchestrated experimentation through vendor‑agnostic integration that unites modular precision automation, scientific analysis and lab management software, complete lab digitization and an AI‑ready open data backbone.

Chemspeed Technologies (a Bruker company) and Atinary proudly hosted a landmark event at Chemspeed’s headquarters in Fuellinsdorf, Switzerland. The opening of the demonstrator lab showcased a breakthrough in laboratory innovation: direct machine-to-machine interaction powered by closed-loop AI and robotics.